ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,099.96
1.02%
US Tech 100
17,320.80
0.47%
Dow Jones
38,239.66
0.00%
Brent Oil
88.095
0.47%
Bitcoin
62,297.54
-1.12%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
Unknown symbol
Date:
Sort by:
DateTimeSourceHeadlineSymbolCompany
04/29/20248:06AMBusiness WireArduino at Automate 2024: Empowering a New Generation of Engineers with Industrial IoT
04/29/20248:05AMBusiness WireJohn R. “Johnny” Braniff, Jr. Joins Alliant Insurance Services, Expands Team in Houston
04/29/20248:05AMBusiness WirePC Gaming Week 2024 Downloads to NeweggNASDAQ:NEGGNewegg Commerce Inc
04/29/20248:05AMPR Newswire (US)Fathom Realty Celebrates the Success of Fathom Serves InitiativeNASDAQ:FTHMFathom Holdings Inc
04/29/20248:05AMPR Newswire (US)Newsweek Selects Caristo Diagnostics as One of World's Best Digital Health Companies
04/29/20248:05AMPR Newswire (US)Artivion Announces Presentation of New Clinical Data for On-X Aortic Heart Valve and AMDS at the 104th American Association for Thoracic Surgery (AATS) Annual MeetingNYSE:AORTArtivion Inc
04/29/20248:05AMPR Newswire (US)Accord BioPharma, Inc. Announces U.S. Food & Drug Administration Approval of HERCESSI™ (trastuzumab-strf), a biosimilar to Herceptin® (trastuzumab) for the Treatment of Several Forms of HER2-Overexpressing Cancer
04/29/20248:05AMGlobeNewswire Inc.Sight Sciences Announces Successful $34 Million Patent Infringement Verdict Against Alcon and its Hydrus Microstent for Microinvasive Glaucoma SurgeryNASDAQ:SGHTSight Sciences Inc
04/29/20248:05AMPR Newswire (US)Newsweek Selects Caristo Diagnostics as One of World's Best Digital Health Companies
04/29/20248:05AMPR Newswire (US)ANCHIN AGAIN NAMED ONE OF THE BEST COMPANIES TO WORK FOR IN NEW YORK
04/29/20248:03AMPR Newswire (US)Pet Wants Wraps Up One of its Best Quarters to Date, Eyes 200-Unit Milestone
04/29/20248:03AMPR Newswire (US)Bolt TV Announces Original Series with Quarterback Bo Nix "Grit & Glory: Journey To The Draft"
04/29/20248:03AMGlobeNewswire Inc.Introducing Brillion, an AI-powered, customer-engagement application suite that enables utilities to scale and optimize energy efficiency, demand-side management (DSM) and clean energy programs, reflecting dynamic market needs
04/29/20248:02AMBusiness WireNew Quarterly Awards Program Celebrates SmartBear Customers
04/29/20248:01AMPR Newswire (US)Equinix Releases Annual Sustainability Report, Highlighting Advancements in Environmental, Social and Governance (ESG) GoalsNASDAQ:EQIXEquinix Inc
04/29/20248:01AMPR Newswire (Canada)Le Collège Villa Maria poursuivra l'œuvre de la CND sur le site actuel
04/29/20248:01AMPR Newswire (Canada)Villa Maria High School to pursue the works of the CND on its current site
04/29/20248:01AMPR Newswire (Canada)Celebrate Cinco de Mayo with Espolòn® Tequila's free Limited Edition Streetwear Collection release, in partnership with Vancity Original® and PARANOID®
04/29/20248:00AMGlobeNewswire Inc.Genco Shipping & Trading Limited Shareholders Invited to Webcast with Board and Management TeamNYSE:GNKGenco Shipping and Trading Limited
04/29/20248:00AMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsAMEX:PLYM-APlymouth Industrial REIT Inc
04/29/20248:00AMGlobeNewswire Inc.AMG to Announce First-Quarter Results on May 6, 2024NYSE:AMGAffiliated Managers Group Inc
04/29/20248:00AMGlobeNewswire Inc.Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross ProceedsNASDAQ:ATXIAvenue Therapeutics Inc
04/29/20248:00AMGlobeNewswire Inc.Avenue Therapeutics Announces Exercise of Warrants for $4.4 Million in Gross ProceedsNASDAQ:FBIOFortress Biotech Inc
04/29/20248:00AMInvestorsHub NewsWireAvant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data CentersUSOTC:AVAIAvant Technologies Inc (QB)
04/29/20248:00AMBusiness WireLVXP Announces Plans to Deliver Experiential Mixed-Use Development Anchored by Entertainment and Sports Arena on Las Vegas Strip
04/29/20248:00AMGlobeNewswire Inc.Celebrate Mother’s Day at Zehnder’s of Frankenmuth
04/29/20248:00AMBusiness WireViridian Therapeutics to Webcast First Quarter 2024 Financial Results on May 8, 2024NASDAQ:VRDNViridian Therapeutics Inc
04/29/20248:00AMBusiness WireAvenacy Announces Launch of Eptifibatide for Injection in the U.S. Market
04/29/20248:00AMBusiness WireTalkspace Launches Behavioral Health Consortium of Specialized Care and Treatment Programs, Expanding In-Network Offerings for MembersNASDAQ:TALKTalkspace Inc
04/29/20248:00AMBusiness WireSimply Healthcare Funds Scholarships for Miami Dade College Certified Nurse Assistant Program During Summer Cohort

Your Recent History

USOTC
VXIT
Virexit Technologies (PK)
COIN
SHIBUSD
SHIBA INU
USOTC
CLNV
Clean Vision (QB)
NASDAQ
AMRN
Amarin
USOTC
IFUS
Impact Fusion (PK)
USOTC
RDGL
Vivos (QB)
NASDAQ
COOP
Mr Cooper
USOTC
BIEL
Bioelectronics (PK)
COIN
BTCUSD
Bitcoin
NASDAQ
RVNC
Revance Therapeutics
USOTC
GVSI
Good Vibrations Shoes (PK)
USOTC
AXXA
Exxe (PK)
USOTC
IPIX
Innovation Pharmaceuticals (CE)
USOTC
NSAV
Net Savings Link (PK)
USOTC
TPTW
TPT Global Tech (CE)
USOTC
AABB
Asia Broadband (PK)
Delayed Upgrade Clock
ADVFN Logo

United States
Company
Business
Popular
Get The App

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved